Noor Shaker

Part of X-Chem, Inc. (Massachusetts), Glamorous AI Ltd. is a British company that is radically changing how drugs are designed and optimized using their proprietary artificial intelligence platform, RosalindAI. The company is based in London, UK. The company specializes in solving challenges inherent to sparse and noisy data sets that make the majority of disease-associated targets intractable by existing computational technologies. By building transformative AI solutions and integrating with biology and chemistry, they empower organizations to discover new drugs and deliver the right drug to the right patient. The CEO of the company is Noor Shaker. Glamorous AI was acquired by X-Chem, Inc. (Massachusetts) on October 28, 2021.

Enko Chem, Inc. operates as a biotechnology company. The company was founded by Jacqueline Heard and is headquartered in Boston, MA.

GTN Ltd. provides drug discovery platform, which intends to develop drugs. Its software combines and builds upon techniques from machine learning and quantum physics to simulate filter and search for molecules, discovering molecules entirely hidden from view. The company was founded by Noor Shaker and Vid Stojevic and is headquartered in London, the United Kingdom.